Shankar Ramaswamy, Kriya Therapeutics CEO
Kriya Therapeutics buys scientific advisor’s NASH gene therapy company
Shankar Ramaswamy’s Kriya Therapeutics has acquired another gene therapy startup for an undisclosed amount.
Kriya has purchased Tramontane Therapeutics, a chronic liver disease gene therapy …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.